In one report, a patient with an L576P KIT mutation in whom imatinib therapy had previously failed experienced marked reduction in tumor burden in response to
dasatinib treatment.
Not exact matches
The researchers confirmed these findings in a mammary carcinoma mouse model —
treatment with
dasatinib just a few days after administering two high doses of chemotherapy prevented tumor growth and increased survival rates.
Because
dasatinib is already cleared for clinical use, researchers hope that progress can be made more quickly towards trialling the drug in humans as a
treatment for DMD.
During his time at Bristol - Myers Squibb, he facilitated a discovery program ultimately leading to the development and launch of Sprycel ® (
dasatinib), a
treatment for chronic myeloid leukemia.